These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18596414)

  • 1. Induction of apoptosis in arsenic trioxide-treated lung cancer A549 cells by buthionine sulfoximine.
    Han YH; Kim SZ; Kim SH; Park WH
    Mol Cells; 2008 Aug; 26(2):158-64. PubMed ID: 18596414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of arsenic trioxide-induced apoptosis in HeLa cells by diethyldithiocarbamate or buthionine sulfoximine.
    Han YH; Kim SZ; Kim SH; Park WH
    Int J Oncol; 2008 Jul; 33(1):205-13. PubMed ID: 18575767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
    Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
    You BR; Park WH
    Oncol Rep; 2012 Aug; 28(2):749-57. PubMed ID: 22684917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH.
    Han YH; Kim SZ; Kim SH; Park WH
    Cancer Lett; 2008 Oct; 270(1):40-55. PubMed ID: 18539383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the resveratrol and arsenic trioxide combination induced apoptosis and its mechanism on lung adenocarcinoma cells].
    Gu S; Chen C; Jiang X; Zhang Z
    Wei Sheng Yan Jiu; 2016 Jan; 45(1):87-92. PubMed ID: 26987203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
    Maeda H; Hori S; Ohizumi H; Segawa T; Kakehi Y; Ogawa O; Kakizuka A
    Cell Death Differ; 2004 Jul; 11(7):737-46. PubMed ID: 15002036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BIMEL is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine.
    Tanaka Y; Komatsu T; Shigemi H; Yamauchi T; Fujii Y
    BMC Cancer; 2014 Jan; 14():27. PubMed ID: 24428916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
    Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):188-91. PubMed ID: 18756933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells.
    Duechler M; Stańczyk M; Czyz M; Stepnik M
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):727-37. PubMed ID: 17594095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.
    Gu S; Chen C; Jiang X; Zhang Z
    Chem Biol Interact; 2016 Feb; 245():100-9. PubMed ID: 26772155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of arsenic trioxide on cell death, reactive oxygen species and glutathione levels in different cell types.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Int J Mol Med; 2010 Jan; 25(1):121-8. PubMed ID: 19956910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
    Ramos AM; Aller P
    Biochem Pharmacol; 2008 May; 75(10):1912-23. PubMed ID: 18359480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydroartemisinin Sensitizes Human Lung Adenocarcinoma A549 Cells to Arsenic Trioxide via Apoptosis.
    Chen H; Gu S; Dai H; Li X; Zhang Z
    Biol Trace Elem Res; 2017 Oct; 179(2):203-212. PubMed ID: 28261759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in arsenic trioxide-treated Calu-6 lung cells is correlated with the depletion of GSH levels rather than the changes of ROS levels.
    Han YH; Kim SH; Kim SZ; Park WH
    J Cell Biochem; 2008 Jun; 104(3):862-78. PubMed ID: 18393359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of arsenic trioxide (As2O3) combined with BSO on K562/ADM cell and its mechanisms].
    Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):438-43. PubMed ID: 18072624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.
    Wang R; Liu C; Xia L; Zhao G; Gabrilove J; Waxman S; Jing Y
    Clin Cancer Res; 2012 Dec; 18(24):6690-701. PubMed ID: 23082001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
    Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
    Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH
    Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.